Medical Practice Acquisition Opportunities in Delaware
4,560 Medicare providers with $434.2M in total revenue. Estimated $152.0M in unrealized revenue across the state.
4,560
$434.2M
$95K
$152.0M
547
1,915
Specialty Hotspots
Which specialties in Delaware have the most acquisition upside
| Specialty | Providers | Avg Revenue | Avg Patients | Total Revenue |
|---|---|---|---|---|
1Nurse Practitioner | 670 | $36K | 141 | $24.2M |
2Physical Therapist in Private Practice | 462 | $61K | 101 | $28.1M |
3Physician Assistant | 416 | $36K | 143 | $14.8M |
4Internal Medicine | 350 | $94K | 235 | $33.1M |
5Family Practice | 282 | $100K | 247 | $28.1M |
6Certified Registered Nurse Anesthetist (CRNA) | 184 | $14K | 53 | $2.6M |
7Emergency Medicine | 161 | $63K | 297 | $10.1M |
8Chiropractic | 150 | $18K | 59 | $2.6M |
9Optometry | 112 | $55K | 277 | $6.1M |
10Licensed Clinical Social Worker | 102 | $18K | 21 | $1.8M |
11Diagnostic Radiology | 100 | $165K | 755 | $16.5M |
12Mass Immunizer Roster Biller | 82 | $84K | 286 | $6.9M |
13Obstetrics & Gynecology | 74 | $14K | 81 | $1.0M |
14General Surgery | 74 | $42K | 85 | $3.1M |
15Anesthesiology | 73 | $36K | 91 | $2.7M |
Top Acquisition Targets in Delaware
Practices with the highest acquisition upside based on patient volume, revenue gaps, and optimization potential
Murtaza Bhatti
Internal Medicine
3,612
$234K
+$1.7M
+712%
Ritu Rastogi
Internal Medicine
1,655
$517K
+$353K
+68%
Nicholas Mandalakas
Cardiology
1,324
$291K
+$278K
+96%
Gilbert Leidig
Cardiology
2,013
$440K
+$426K
+97%
Ripudaman Hundal
Endocrinology
1,952
$380K
+$439K
+115%
Thomas Burke
Dermatology
1,654
$445K
+$498K
+112%
Michael Saruk
Dermatology
1,328
$379K
+$378K
+100%
Matthew Hanson
Dermatology
4,378
$1.0M
+$1.5M
+142%
Mouhanad Freih
Cardiology
1,800
$796K
+$0
+0%
Helen Mashek
Dermatology
1,356
$394K
+$380K
+97%
Michael Rosenthal
Dermatology
1,402
$533K
+$267K
+50%
Lori Spencer
Dermatology
1,367
$432K
+$348K
+80%
Get Acquisition Intelligence for Delaware
Premium analytics for Delaware healthcare acquisitions. Automated deal flow, real-time scoring, and portfolio optimization.
No spam. Just a one-time launch notification with early-bird pricing.